Biliary Obstruction

Duct dilatation tells me that the biliary tree has changed caliber, but it does not independently identify an active blockage. I follow the distribution of that change toward its anatomical cause and interpret it against symptoms, laboratory results, and prior procedures.

Clinical overview

Biliary obstruction is impaired bile drainage caused by a mechanical blockage or narrowing. Patients may have jaundice, dark urine, pale stools, pruritus, or abdominal pain. Some abnormalities are discovered while investigating liver tests or an unrelated imaging finding.

A cholestatic biochemical pattern usually involves a disproportionate elevation of alkaline phosphatase relative to aminotransferases, interpreted against the laboratory’s reference ranges. It supports impaired bile handling but does not establish extrahepatic obstruction. Hepatocellular disease, medication effects, and intrahepatic cholestatic disorders remain possible explanations.

I would separate three questions: whether bile flow is mechanically obstructed, where the obstruction lies, and whether infection or organ dysfunction makes drainage urgent. Fever with jaundice has different implications from stable asymptomatic duct prominence. Painless jaundice raises concern for malignancy but does not establish it.

Anatomy and pathophysiology

Distribution localizes the affected drainage pathway

Right and left hepatic ducts join to form the common hepatic duct. The cystic duct joins this pathway, below which the channel is termed the common bile duct. The distal duct courses toward the duodenum through the pancreatic-head region.

A distal obstruction can dilate both extrahepatic and intrahepatic ducts. A hilar lesion can dilate intrahepatic branches while leaving the distal duct relatively small. A segmental obstruction may affect only one drainage territory. I would therefore describe which branches are abnormal instead of reducing the examination to the largest diameter.

An impacted gallbladder-neck or cystic-duct stone can compress the adjacent common hepatic duct, producing Mirizzi syndrome. The stone is then outside the obstructed main duct. Vardar and colleagues illustrate this relationship on ultrasound. I read it as a useful counterexample to the assumption that stone-related obstruction always requires a stone inside the common bile duct.

Caliber is a delayed and context-dependent response

Duct enlargement depends on obstruction duration, completeness, and duct compliance. Early or intermittent obstruction may produce little dilatation. Conversely, enlargement can remain after the obstructing process has resolved.

Age and previous cholecystectomy also influence caliber. The review by Lucius and colleagues documents variation across measurement techniques and patient groups. I would not treat an age-adjusted or postoperative reference range as permission to ignore new symptoms or a changing duct.

Mechanical causes include intraluminal stones, mural strictures, tumors, and external compression. Their common consequence is impaired drainage, but their imaging evidence differs. A filling defect, an enhancing duct-wall lesion, and a pancreatic mass should not become interchangeable annotations.

Diagnostic workflow and imaging findings

Establish the clinical timeline and prior anatomy

I would record the onset of pain or jaundice, trends in bilirubin and liver enzymes, and any previous cholecystectomy, sphincterotomy, stent placement, or biliary reconstruction. The date of each intervention matters because it can alter both duct caliber and intraductal contents.

The ACR jaundice guidance organizes imaging around the suspected mechanism. Ultrasound is useful for an initial assessment of duct dilatation, gallstones, and liver abnormalities. However, an examination aimed at explaining jaundice must consider processes that do not mechanically obstruct a duct.

A laboratory sample collected after drainage should not be paired uncritically with an image obtained before drainage. I would preserve these as observations from different physiological states.

Identify ducts through continuity and Doppler

Dilated intrahepatic ducts appear as branching fluid-filled structures accompanying portal branches. Parallel tubular structures can create a recognizable pattern, but vessels must be excluded. Doppler helps when the settings are appropriate for the expected flow.

Absent color alone does not prove that a structure is a duct. Slow flow, unfavorable insonation, or excessive filtering can suppress vascular signals. Tracing continuity across a sweep is more reliable than classifying one dark circular cross-section.

I would measure the extrahepatic duct inner wall to inner wall, perpendicular to its long axis, and document the location. Including wall tissue or measuring obliquely overestimates the lumen. The cystic duct junction may be unseen, so anatomical naming should match what was actually demonstrated.

Locate the transition and distinguish direct from indirect evidence

The examination should follow dilated ducts toward a narrowing, cutoff, intraluminal focus, or surrounding mass. The distal common bile duct is often limited by bowel gas. Repositioning and alternate windows can help, but a persistently unseen segment must remain explicit in the report.

A shadowing echogenic focus demonstrably within the duct is direct evidence of a stone. Upstream dilatation without a visible cause is indirect evidence of impaired drainage. Gallbladder stones increase the plausibility of migration but do not demonstrate a current duct stone.

In a hypothetical jaundiced patient, ultrasound shows dilated intrahepatic ducts and proximal extrahepatic duct, but the distal duct is obscured. The useful conclusion is suspected downstream obstruction with an undetermined cause. Calling this choledocholithiasis would convert a plausible explanation into an observed finding.

In another hypothetical case, only the left intrahepatic branches are dilated while the distal duct is small. I would investigate a more proximal or segmental process. A normal distal measurement cannot exclude obstruction upstream from it.

Select further imaging by the unanswered question

MRCP uses heavily T2-weighted sequences to depict relatively static fluid in the biliary and pancreatic ducts. It can map strictures and filling defects without duct cannulation. Contrast-enhanced MRI sequences answer additional questions about tissue and enhancement; they are not identical to MRCP itself.

A dark filling defect on MRCP is not automatically a stone. Air, debris, flow effects, and reconstruction artifacts can mimic pathology. Maximum-intensity projections may obscure a small defect, so source images matter. Griffin, Charles-Edwards, and Grant describe these interpretation pitfalls.

Contrast-enhanced CT or MRI can investigate a pancreatic, hilar, or gallbladder mass and surrounding structures. Endoscopic ultrasound can clarify distal duct or periampullary abnormalities. ERCP provides access for drainage, extraction, or sampling, with procedural risks that discourage its indiscriminate use as a purely diagnostic test.

Differential diagnosis and management context

Nonobstructive duct enlargement, recently relieved obstruction, and active mechanical obstruction can share a prominent duct. Hepatitis, medication-related cholestasis, and other intrahepatic disorders can produce abnormal liver tests without the expected obstructive pattern. The combination of clinical course and adequate imaging determines which explanation remains plausible.

Prior biliary intervention introduces additional findings. Pneumobilia can occur after sphincterotomy or a biliary-enteric connection, and stents create reflective interfaces. These appearances require procedural context before being interpreted as stones or infection.

Management follows the cause and urgency. An infected obstructed system requires antimicrobial treatment, resuscitation, and source-control planning. A stable indeterminate stricture requires deliberate characterization and an appropriate tissue strategy. Diagnostic completeness should not delay necessary treatment of an unstable patient.

I would also distinguish successful drainage from definitive treatment. A stent may relieve obstruction while the underlying malignant or benign stricture remains. An image acquired after decompression can therefore show less dilatation without demonstrating resolution of the cause.

Implications for medical AI

Define a hierarchy of targets with separate references

I would distinguish duct detection, caliber measurement, obstruction localization, cause classification, and clinical urgency. Each needs a different reference. Reader measurements can support a diameter task; MRCP, EUS, ERCP, surgery, or longitudinal assessment may contribute to an obstruction reference. Infection requires clinical evidence.

A classifier trained on “biliary obstruction” could succeed by recognizing dilatation while failing on nondilated obstruction or persistent postoperative enlargement. I would deliberately include these discordant groups and report performance separately.

For localization, readers could annotate intrahepatic distribution, proximal duct visibility, distal duct visibility, and the most distal demonstrated abnormal segment. An unvisualized segment would remain unknown. Filling missing anatomy with a normal label would reward unsupported certainty.

Test whether the model uses measurements or their annotation

A specific shortcut pathway begins when the operator suspects a dilated duct, freezes the view, places calipers, and exports the image. The calipers are consequences of clinical attention and may reveal which cases were considered abnormal.

I would compare identical frames with and without overlays where available. A separate audit would test whether the model distinguishes the duct from adjacent vessels using cine continuity or paired Doppler information. A heatmap over the porta hepatis would not establish either capability.

For a measurement model, I would examine error by measurement location, obliquity, visibility, and prior surgery. Good average agreement could conceal systematic overmeasurement of oblique distal segments.

Use temporal discordance as an audit opportunity

An attackable question is whether obstruction scores remain high after documented drainage because the duct remains enlarged. Paired examinations could connect score changes to caliber, visible cause, and treatment timing.

This comparison would remain observational because drainage also changes symptoms, contents, and acquisition conditions. Still, it would identify whether a model advertised as detecting active obstruction behaves mainly as a duct-size detector.

I would also compare direct-cause and indirect-sign cases at similar caliber. This asks whether visible lesion evidence adds information beyond dilatation. If gallbladder-only exports omit the ducts, the first research task is to recover the relevant examination views rather than assign a ductal diagnosis to unsupported frames.

References

• Lucius et al., Ultrasound of Bile Ducts: An Update on Measurements, Reference Values, and Their Influencing Factors, Diagnostics 2025.
• Hindman et al., ACR Appropriateness Criteria: Jaundice, Journal of the American College of Radiology 2019.
• Griffin, Charles-Edwards, and Grant, Magnetic resonance cholangiopancreatography: the ABC of MRCP, Insights into Imaging 2012.
• Vardar et al., Ultrasonographic evaluation of patients with abnormal liver function tests in the emergency department, Ultrasonography 2022.